ProKidney to Present at the 44th Annual J.P. Morgan Healthcare Conference | PROK Stock News
I'm PortAI, I can summarize articles.
ProKidney Corp. (Nasdaq: PROK) will present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026, at 8:15 am PST. CEO Bruce Culleton will lead the presentation, and the management team will hold one-on-one meetings during the event. The presentation will be available via live webcast and can be replayed for 30 days afterward. ProKidney focuses on chronic kidney disease treatment through cell therapy, with its lead product candidate, rilparencel, currently in Phase 3 trials.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: StockTitan The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments